Autolus Therapeutics (AUTL) Earnings Date, Estimates & Call Transcripts $1.33 +0.04 (+3.10%) Closing price 04:00 PM EasternExtended Trading$1.33 0.00 (0.00%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Autolus Therapeutics Earnings Summary Autolus Therapeutics posted Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.26, which missed the consensus estimate of -$0.24 by $0.02. Quarterly revenue was reported to be $8.98 million, above the consensus estimate of $1.59 million. With a trailing EPS of -$0.88, Autolus Therapeutics' earnings are expected to grow next year, from ($0.94) to ($0.83) per share. Latest Q1 Earnings DateMay. 8EstimatedConsensus EPS (May. 8) -$0.24 Actual EPS (May. 8) -$0.26 Missed By -$0.02 Actual Revenue (May. 8) $8.98MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Quarterly Report (10-Q)Slide DeckFull Screen Slide DeckPowered by Get Autolus Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Autolus Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAUTL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AUTL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Autolus Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.24-$0.24-$0.24Q2 20251-$0.25-$0.25-$0.25Q4 20251-$0.20-$0.20-$0.20 2025 3 -$0.69 -$0.69 -$0.69 Q1 20261-$0.27-$0.27-$0.27Q2 20261-$0.28-$0.28-$0.28Q3 20261-$0.23-$0.23-$0.23Q4 20261-$0.18-$0.18-$0.18 Autolus Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025-$0.24-$0.26 -$0.02-$0.26$1.59M$8.98M3/20/2025Q4 2024-$0.21-$0.09+$0.12-$0.09$2.98M$0.03M11/12/2024Q3 2024-$0.21-$0.31 -$0.10-$0.31$0.40M-8/8/2024Q2 2024-$0.19-$0.22 -$0.03-$0.22--5/17/2024Q1 2024-$0.10-$0.24 -$0.14-$0.24$50.00M$10.09M3/14/2024Q4 2023-$0.26-$0.44 -$0.18-$0.44--11/2/2023Q3 2023-$0.24-$0.26 -$0.02-$0.26$2.00M$0.41M8/3/2023Q2 2023-$0.22-$0.26 -$0.04-$0.26-- Autolus Therapeutics Earnings - Frequently Asked Questions When did Autolus Therapeutics announce their last quarterly earnings? Autolus Therapeutics (NASDAQ:AUTL) last announced its quarterly earning data on Thursday, May 8, 2025. Learn more on AUTL's earnings history. Did Autolus Therapeutics beat their earnings estimates last quarter? In the previous quarter, Autolus Therapeutics (NASDAQ:AUTL) missed the analysts' consensus estimate of ($0.24) by $0.02 with a reported earnings per share (EPS) of ($0.26). Learn more on analysts' earnings estimate vs. AUTL's actual earnings. How can I listen to Autolus Therapeutics's earnings conference call? The conference call for Autolus Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Autolus Therapeutics's conference call transcript? The conference call transcript for Autolus Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Autolus Therapeutics generate each year? Autolus Therapeutics (NASDAQ:AUTL) has a recorded annual revenue of $9.01 million. How much profit does Autolus Therapeutics generate each year? Autolus Therapeutics (NASDAQ:AUTL) has a recorded net income of -$208.38 million. AUTL has generated -$0.88 earnings per share over the last four quarters. What is Autolus Therapeutics's EPS forecast for next year? Autolus Therapeutics's earnings are expected to grow from ($0.94) per share to ($0.83) per share in the next year. More Earnings Resources from MarketBeat Related Companies Vera Therapeutics Earnings Results Dyne Therapeutics Earnings Results Structure Therapeutics Earnings Results ANI Pharmaceuticals Earnings Results ARS Pharmaceuticals Earnings Results Calliditas Therapeutics AB (publ) Earnings Results 89bio Earnings Results Ocular Therapeutix Earnings Results Amphastar Pharmaceuticals Earnings Results Aurinia Pharmaceuticals Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NASDAQ:AUTL) was last updated on 5/16/2025 by MarketBeat.com Staff From Our PartnersWashington Is Broke—and Eyeing Your Savings NextWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowMusk has launched a bold new AI initiative—and while you can’t invest in it directly, one overlooked stock cou...Behind the Markets | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredA New Wealth Divide Is Forming NowOver the years, my proprietary stock system has identified some of the biggest winners long before Wall Street...InvestorPlace | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored How much money will YOU make when gold hits $5,000?What if I told you there was a way to secure a shot at making asymmetric gains from gold’s current historic bu...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autolus Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Autolus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AUTL Stock Free AUTL Stock Alerts